| 000 | 00932 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516151611.0 | ||
| 264 | 0 | _c20140213 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1876-2891 | ||
| 024 | 7 |
_a10.3920/BM2013.0019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBinnendijk, K H | |
| 245 | 0 | 0 |
_aWhat is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics. _h[electronic resource] |
| 260 |
_bBeneficial microbes _cSep 2013 |
||
| 300 |
_a223-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aDrug Evaluation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsurance Benefits |
| 650 | 0 | 4 |
_aProbiotics _xtherapeutic use |
| 650 | 0 | 4 | _aTerminology as Topic |
| 700 | 1 | _aRijkers, G T | |
| 773 | 0 |
_tBeneficial microbes _gvol. 4 _gno. 3 _gp. 223-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3920/BM2013.0019 _zAvailable from publisher's website |
| 999 |
_c22762228 _d22762228 |
||